Ipamorelin
Prescription OnlyOverview
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It is one of the most commonly compounded peptides in Australia, typically prescribed alongside CJC-1295. No regulatory changes are anticipated.
Australian Scheduling
Schedule 4 (Prescription Only). Well-established in the Australian compounding pharmacy system. No scheduling changes anticipated for 2026-2027.
Access Pathway
Widely available through telehealth clinics and compounding pharmacies. Standard prescription pathway with 15 identified providers. Often prescribed as part of a CJC-1295/Ipamorelin protocol.
For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.